BioCentury
ARTICLE | Strategy

Mixing it up at Karolinska

November 20, 2014 8:00 AM UTC

By pretty much every measure, the Karolinska Institute has all the tools in place to ensure its academic discoveries with translational potential find a home-either in a startup or via an industry partnership.

The institute has top-tier research, a hospital and a deal with Karolinska Development AB, which is a company that in-licenses discoveries from multiple Nordic universities, develops them to a commercially attractive point and then out-licenses or sells the asset...